Literature DB >> 16775835

Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression.

Chang Xia1, Qiao Meng, Zongxian Cao, Xianglin Shi, Bing-Hua Jiang.   

Abstract

Recent studies demonstrate that PI3K activation and PTEN mutation are frequently found in many human cancer cells and tissues. However, the mechanism of PI3K signaling in human cancer tumorigenesis remains to be elucidated. In this study we specifically downregulated p110alpha expression in ovarian cancer cells using siRNA interference. We found that p110alpha downregulation greatly decreased ovarian tumor growth and angiogenesis, and that p110alpha siRNA inhibited VEGF expression through decreasing hypoxia-inducible factor 1alpha expression in both ovarian cancer cells and tumor tissues. To determine the downstream targets of PI3K in regulating tumor growth and angiogenesis, we find that AKT1 is a major downstream mediator for regulating tumor growth, angiogenesis, and VEGF expression. These data show that p110alpha and AKT1 play an important role in tumor growth by inducing angiogenesis and by increasing HIF-1alpha and VEGF expression. This work provides a better understanding of the molecular mechanism of human cancer induced by the activation of PI3K signaling. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775835     DOI: 10.1002/jcp.20707

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  34 in total

1.  D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.

Authors:  S M El Sayed; R M Abou El-Magd; Y Shishido; K Yorita; S P Chung; D H Tran; T Sakai; H Watanabe; S Kagami; K Fukui
Journal:  J Bioenerg Biomembr       Date:  2012-07-17       Impact factor: 2.945

2.  ADAM17 promotes glioma cell malignant phenotype.

Authors:  Xuguang Zheng; Feng Jiang; Mark Katakowski; Yong Lu; Michael Chopp
Journal:  Mol Carcinog       Date:  2011-04-07       Impact factor: 4.784

Review 3.  The role of ADAM17 in tumorigenesis and progression of breast cancer.

Authors:  Hongyu Shen; Liangpeng Li; Siying Zhou; Dandan Yu; Sujin Yang; Xiu Chen; Dandan Wang; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  Tumour Biol       Date:  2016-09-22

4.  PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia.

Authors:  Cheng Zhiyong; Liang Wentong; Yang Xiaoyang; Pan Ling
Journal:  Med Oncol       Date:  2011-03-01       Impact factor: 3.064

5.  Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.

Authors:  Monika Paul-Samojedny; Adam Pudełko; Renata Suchanek-Raif; Małgorzata Kowalczyk; Anna Fila-Daniłow; Paulina Borkowska; Jan Kowalski
Journal:  Tumour Biol       Date:  2014-12-14

6.  Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN.

Authors:  Lance A Stechschulte; Leah Wuescher; Joseph S Marino; Jennifer W Hill; Charis Eng; Terry D Hinds
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

7.  PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.

Authors:  Jing Fang; Min Ding; Lily Yang; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Cell Signal       Date:  2007-08-15       Impact factor: 4.315

Review 8.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

9.  ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.

Authors:  Xuguang Zheng; Feng Jiang; Mark Katakowski; Zheng Gang Zhang; Qing-e Lu; Michael Chopp
Journal:  Cancer Biol Ther       Date:  2009-06-25       Impact factor: 4.742

10.  Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.

Authors:  Martin Michaelis; Denise Klassert; Susanne Barth; Tatyana Suhan; Rainer Breitling; Bernd Mayer; Nora Hinsch; Hans W Doerr; Jaroslav Cinatl; Jindrich Cinatl
Journal:  Mol Cancer       Date:  2009-09-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.